3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
52
Prostatic Neoplasms
23
Lung Neoplasms
17
Breast Neoplasms
17
Squamous Cell Carcinoma of Head and Neck
14
Stomach Neoplasms
10
Neoplasms
9
Parkinson Disease 4, Autosomal Dominant Lewy Body
8
Urinary Bladder Neoplasms
6
Neoplasm Metastasis
6
Head and Neck Neoplasms
6
Carcinoma, Transitional Cell
6
Triple Negative Breast Neoplasms
5
Non-Muscle Invasive Bladder Neoplasms
5
Carcinoma, Squamous Cell
5
Prostatic Neoplasms, Castration-Resistant
4
Ovarian Neoplasms
4
Oropharyngeal Neoplasms
4
Endometrial Neoplasms
4
Small Cell Lung Carcinoma
3
Salivary Gland Neoplasms
3
Nasopharyngeal Carcinoma
3
Laryngeal Neoplasms
3
HER2-positive Breast Cancer
3
Fallopian Tube Neoplasms
3
Esophageal Squamous Cell Carcinoma
3
Carcinoma
3
Anatomic Stage I Breast Cancer AJCC v8
3
Adenocarcinoma
3
Vaccinia
2
Interventions
Dexamethasone
7
Bortezomib
6
Cyclophosphamide
5
daratumumab
3
Specimen Handling
3
4-(N-methylamino)-4'-(2-(2-(2-fluoroethoxy)ethoxy)ethoxy)stilbene
3
venetoclax
2
dexamethasone acetate
2
dexamethasone 21-phosphate
2
belantamab mafodotin
2
auricularum
2
X-Rays
2
Phantoms, Imaging
2
Magnetic Resonance Spectroscopy
2
Clinical Protocols
2
Calcium Dobesilate
2
Biopsy
2
ixazomib
1
Tissue Banks
1
Stem Cell Transplantation
1
Pharmaceutical Preparations
1
Melphalan
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Immunoglobulin Light-chain Amyloidosis
×
Docetaxel
×
90 days
×
Clear all
No trials found.